Singular Genomics Systems, Inc.
OMIC
Revenue
737.00k
▲295.00k▲66.74%
3 Months ChangeAssets
220.00M
▼-19.10M▼-7.99%
3 Months ChangeLiabilities
82.30M
▼-107.00k▼-0.1298%
3 Months ChangeFree Cash Flow
-23.73M
▼-5.63M▼-31.12%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-19
Form 8-K
ID: 0000950170-24-108189
2024-09-12
Form 8-K
ID: 0000950170-24-105974
2024-08-13
Form 10-Q
ID: 0000950170-24-096192
2024-08-13
Form 8-K
ID: 0000950170-24-096176
2024-08-07
Form 8-K
ID: 0000950170-24-092729
2024-07-15
Form 8-K
ID: 0000950170-24-083564
2024-06-27
Form 8-K
ID: 0000950170-24-078167
2024-05-30
Form 8-K
ID: 0000950170-24-066679
2024-05-14
Form 10-Q
ID: 0000950170-24-059533
2024-05-14
Form 8-K
ID: 0000950170-24-059523